Collaboration combines AI-ready data platforms with delivery certainty to help life sciences and food companies move faster—from strategy to measurable outcomesCollaboration combines AI-ready data platforms with delivery certainty to help life sciences and food companies move faster—from strategy to measurable outcomes

L7 Informatics and Turnberry Solutions Announce Strategic Teaming Agreement to Accelerate Life Sciences Innovation at Enterprise Scale

2026/01/09 00:47
4분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

Collaboration combines AI-ready data platforms with delivery certainty to help life sciences and food companies move faster—from strategy to measurable outcomes.

AUSTIN, Texas & MINNEAPOLIS–(BUSINESS WIRE)–L7 Informatics, Inc., and Turnberry Solutions, Inc. today announced the completion of a strategic Teaming Agreement, establishing a formal collaboration to jointly pursue enterprise digital transformation initiatives across the life sciences and food industries. The partnership is designed to help organizations accelerate innovation, modernize operations, and achieve measurable business outcomes, while maintaining speed, scale, and execution certainty.

Life sciences enterprises are under mounting pressure to move faster while navigating fragmented data environments, complex regulatory requirements, and growing expectations around AI adoption. Yet many struggle to find partners who can pair strategic vision with real-world execution velocity. Clients are increasingly demanding speed, scale, and substance, and this teaming agreement is purpose-built to deliver exactly that.

By combining L7 Informatics’ unified, AI-ready data platform (L7|ESP) with Turnberry’s business-outcome-first, cloud-exclusive digital services model, the two companies will provide clients with an integrated path from data foundation to enterprise impact. Together, they will support large, multi-site implementations, predictable deployments, and faster time-to-value across research, development, and manufacturing environments.

“Life sciences organizations don’t need more disconnected tools or abstract roadmaps; they need a unified platform and a partner who can execute with precision,” said Mark Spencer, President & CEO of L7 Informatics. “Turnberry brings a rare combination of delivery certainty, deep life sciences expertise, and enterprise-scale execution. This partnership strengthens our ability to help customers eliminate data silos, become truly AI-ready, and turn scientific data into operational and clinical advantage.”

L7 Informatics’ L7|ESP platform replaces fragmented LIMS, ELN, MES, and scheduling systems with a single, ontology-driven solution that contextualizes data at the point of capture and orchestrates end-to-end workflows. The result is a unified, AI-ready data foundation that accelerates drug development, reduces operational friction, and enables advanced analytics and machine learning, without requiring a disruptive rip-and-replace of existing systems.

Turnberry Solutions redefines digital services through a delivery-certainty-driven approach that combines boutique agility with global scale. Serving seven of the world’s top ten pharmaceutical companies, Turnberry helps life sciences organizations advance patient outcomes through simplification, optimization, digital health, advanced AI, and regulatory-aware transformation.

“Our clients expect outcomes, not experiments,” said Bill Ravenscroft, CEO of Turnberry Solutions. “L7’s platform solves one of the hardest problems in life sciences, creating a true unified, contextualized data that works at enterprise scale. Together, we can move clients from ambition to execution faster, with the confidence that what we design can be delivered, scaled, and sustained.”

The Teaming Agreement reinforces L7 Informatics’ collaborative partner model, enabling certified partners to design, configure, and implement L7|ESP to meet exacting scientific and operational requirements. For customers, the partnership delivers faster deployments, predictable results, stronger pre-sales alignment, and broader access to enterprise transformation initiatives.

As life sciences organizations race to modernize and operationalize AI, L7 Informatics and Turnberry Solutions are positioning themselves as a powerful alliance, one that unites platform innovation with execution excellence to help clients move faster, smarter, and with confidence.

About L7 Informatics

L7 Informatics provides a unified digital platform that eliminates data silos across pharmaceutical, biotech, CDMO, diagnostics, and research organizations. Its L7|ESP platform contextualizes data at the source and orchestrates workflows across research, development, and manufacturing, creating an AI-ready foundation for enterprise-scale innovation. L7 has been recognized by Frost & Sullivan as the Global Leader in Innovation for Pharmaceutical and Biotech LIMS and has appeared on the Deloitte Technology Fast 500 for four consecutive years.

About Turnberry Solutions

Turnberry Solutions is a global digital services company that helps organizations achieve measurable business outcomes through a cloud-exclusive, delivery-certainty-driven model. With deep expertise in life sciences, Turnberry partners with leading enterprises to simplify complexity, accelerate innovation, and deliver transformation at scale.

Contacts

Media Contacts:
Jessica Tobey

L7 Informatics, Inc.

info@L7informatics.com

Ashley Belisle

Turnberry Solutions, Inc.

PR@Turnberrysolutions.com

시장 기회
플러리싱 에이아이 로고
플러리싱 에이아이 가격(SLEEPLESSAI)
$0,01956
$0,01956$0,01956
+2,24%
USD
플러리싱 에이아이 (SLEEPLESSAI) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

USD1 Genesis: 0 Fees + 12% APR

USD1 Genesis: 0 Fees + 12% APRUSD1 Genesis: 0 Fees + 12% APR

New users: stake for up to 600% APR. Limited time!